Warfarin clinical trials antithrombotics

Acute coronary syndrome

ACS (excluding AMI):  7 trials  - Huyhn - OASIS-2 Warfarin Substudy - OASIS Pilot (phase 1) - OASIS Pilot (phase 2) - ATACS - ATACS (pilot study) (warfarin vs control) - ATACS (pilot study) warfarin vs aspirin

All ACS (including AMI):  14 trials  - LoWASA - Zibaeenezhad - APRICOT-2 - CHAMP - WARIS - Huyhn - OASIS-2 Warfarin Substudy - OASIS Pilot (phase 1) - OASIS Pilot (phase 2) - CARS - Williams - ATACS - ATACS (pilot study) (warfarin vs control) - ATACS (pilot study) warfarin vs aspirin

All type of patients:  14 trials  - LoWASA - Zibaeenezhad - APRICOT-2 - CHAMP - WARIS - Huyhn - OASIS-2 Warfarin Substudy - OASIS Pilot (phase 1) - OASIS Pilot (phase 2) - CARS - Williams - ATACS - ATACS (pilot study) (warfarin vs control) - ATACS (pilot study) warfarin vs aspirin

Acute myocardial infarction

All type of patients:  10 trials  - LoWASA - Zibaeenezhad - APRICOT-2 - CHAMP - WARIS II (warfarin alone) - WARIS II (warfarin+ASA) - WARIS - CARS (warafrin 3mg) - CARS (warfarin 1mg) - Williams

Atrial fibrillation

10 trials  - SAFT(warfarin low dose + aspirin vs no treatment) - AFASAK II (warfarin low dose vs warfarin standard dose) - AFASAK II (warfarin low dose+aspirin vs warfarin standard dose) - MWNAF - SPAF III - SPINAF (warfarin vs placebo) - CAFA - SPAF (warfarin standard dose) - BAATAF (warfarin vs no treatment) - AFASAK (warfarin standard dose vs control)

Cardiovascular prevention

All type of patients:  2 trials  - Thrombosis Prevention trial (W plus A) - Thrombosis Prevention trial (Warfarin)

Primary prevention:  2 trials  - Thrombosis Prevention trial (W plus A) - Thrombosis Prevention trial (Warfarin)

Heart failure

All type of patients:  5 trials  - WATCH (warfarin vs aspirin) - HELAS (warfarin vs aspirin) - HELAS (warfarin vs placebo) - WASH (warfarin) - Barzizza (warfarin)

Percutaneous coronary intervention

Peripheral vascular diseases

After revascularisation:  2 trials  - Johnson - Sarac

Post myocardial infarction

10 trials  - LoWASA - Zibaeenezhad - APRICOT-2 - CHAMP - WARIS II (warfarin alone) - WARIS II (warfarin+ASA) - WARIS - CARS (warafrin 3mg) - CARS (warfarin 1mg) - Williams

Post stroke

1 trials  - SWAT

Thrombosis prevention

Orthopedic surgery:  28 trials  - Fitzgerald - Hull - Colwell - van Comp - Francis - Heit - Lotke - Leclerc - RD Heparin - Hull - Francis - Bailey - Gerhart - Kaempffe - Powers - Powers - Paiement - Francis - Barber - Barber - Morris - Hume - Hume - Hume - Harris - Pinto - Myrhe - Myrhe

Venous thrombosis

secondary prevention of VTE :  7 trials  - PROLONG (Palareti) - Agnelli - PREVENT (Ridker) - Agnelli - LAFIT (Kearon) - DURAC (Schulman) - Levine

All type of patients:  9 trials  - ELAET (Kearon) - Agnelli - PREVENT (Ridker) - Agnelli - Pinede - LAFIT (Kearon) - DURAC (Schulman) - Levine - Schulman

Patients with cancer:  1 trials  - Wells (subgroup)